HomeThe Insider’s ViewBusiness ProfilesFewer generics rush to enter market after linagliptin's patent expiry

Business Profiles

Fewer generics rush to enter market after linagliptin's patent expiry

By Alexander Luke

October 19, 2023

Post Views: 55

[ad_1]

When Sitagliptin went off patent, nearly 200 brands were vying for a share of the market

[ad_2]

Source link

Previous article

Airtel, Ericsson test new tech that claims to save devices’ battery on 5G

Next article

Halifax bus driver says staffing ‘stretched to the max’ as more routes get added – Halifax

Alexander Luke https://modernbusinessgermany.com

Editor

RELATED ARTICLES

- Advertisement -

spot_img

Most Popular

spot_img

spot_img

spot_img